TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from Actinogen Medical ( (AU:ACW) ) is now available.
Actinogen Medical Limited announced the cessation of 1,600,000 securities due to the expiry of options or other convertible securities without exercise or conversion. This development may impact the company’s capital structure and could influence investor perceptions regarding its financial strategies and future prospects.
More about Actinogen Medical
Actinogen Medical Limited operates in the biotechnology industry, focusing on developing innovative therapies for cognitive impairment and neurodegenerative diseases. The company is primarily engaged in research and development of treatments that target neurological conditions, aiming to address significant unmet medical needs in this sector.
YTD Price Performance: 28.00%
Average Trading Volume: 2,942,808
Technical Sentiment Signal: Hold
Current Market Cap: A$101.6M
For a thorough assessment of ACW stock, go to TipRanks’ Stock Analysis page.